UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

Journal for immunotherapy of cancer, 2016-10, Vol.4 (1), p.59-59, Article 59

2016

Volltextzugriff (PDF)

Immunotherapy in breast cancer: An introduction

Breast (Edinburgh), 2018-02, Vol.37, p.196-199

2018

Volltextzugriff (PDF)

Advances and challenges in cancer immunoprevention and immune interception

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e007815

2024

Volltextzugriff (PDF)

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review

JAMA oncology, 2016-10, Vol.2 (10), p.1354

2016

Volltextzugriff (PDF)

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Cancers, 2023-08, Vol.15 (17), p.4337

2023

Volltextzugriff (PDF)

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes

Frontiers in oral health, 2022-07, Vol.3

2022

Volltextzugriff (PDF)

Triple-negative breast cancer: immune modulation as the new treatment paradigm

American Society of Clinical Oncology educational book, 2015 (35), p.e25-e30

2015

Volltextzugriff (PDF)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003122

2021

Volltextzugriff (PDF)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

NPJ breast cancer, 2021-05, Vol.7 (1), p.50-50, Article 50

2021

Volltextzugriff (PDF)

Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo

Journal for immunotherapy of cancer, 2016-05, Vol.4 (1), p.27-27, Article 27

2016

Volltextzugriff (PDF)

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

대한암예방학회지, 2021, 26(4), , pp.309-317

2021

Volltextzugriff (PDF)

Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

Nature biotechnology, 2000-09, Vol.18 (9), p.1001-1005

2000

Volltextzugriff (PDF)

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets

Vaccine, 2019-06, Vol.37 (27), p.3552-3561

2019

Volltextzugriff (PDF)

Yaf2 Inhibits Caspase 8-mediated Apoptosis and Regulates Cell Survival during Zebrafish Embryogenesis

The Journal of biological chemistry, 2006-09, Vol.281 (39), p.28782-28793

2006

Volltextzugriff (PDF)

Current methods of epitope identification for cancer vaccine design

Vaccine, 2015-12, Vol.33 (51), p.7408-7414

2015

Volltextzugriff (PDF)

Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?

Nature reviews. Clinical oncology, 2017-12, Vol.14 (12), p.715-716

2017

Volltextzugriff (PDF)

Can immunity to breast cancer eliminate residual micrometastases?

Clinical cancer research, 2013-12, Vol.19 (23), p.6398-6403

2013

Volltextzugriff (PDF)

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

BMC cancer, 2015-04, Vol.15 (1), p.267-267, Article 267

2015

Volltextzugriff (PDF)

The antigenic repertoire of premalignant and high-risk lesions

Cancer prevention research (Philadelphia, Pa.), 2015-04, Vol.8 (4), p.266-270

2015

Volltextzugriff (PDF)

834 Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A932-A932

2023

Volltextzugriff (PDF)

Designing vaccines to prevent breast cancer recurrence or invasive disease

Immunotherapy, 2015-02, Vol.7 (2), p.69-72

2015

Volltextzugriff (PDF)

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

Journal of translational medicine, 2014-05, Vol.12 (1), p.121-121, Article 121

2014

Volltextzugriff (PDF)

Immunotherapy for breast cancer: is it feasible?

Immunotherapy, 2015-11, Vol.7 (11), p.1135-1143

2015

Volltextzugriff (PDF)

Rybp interacts with Hippi and enhances Hippi-mediated apoptosis

Apoptosis (London), 2007-12, Vol.12 (12), p.2197-2206

2007

Volltextzugriff (PDF)

Abstract PR007: Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC

Cancer prevention research (Philadelphia, Pa.), 2022-12, Vol.15 (12_Supplement_1), p.PR007-PR007

2022

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

Immunotherapy in breast cancer: An introduction

Advances and challenges in cancer immunoprevention and immune interception

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review

Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes

Triple-negative breast cancer: immune modulation as the new treatment paradigm

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets

Yaf2 Inhibits Caspase 8-mediated Apoptosis and Regulates Cell Survival during Zebrafish Embryogenesis

Current methods of epitope identification for cancer vaccine design

Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?

Can immunity to breast cancer eliminate residual micrometastases?

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

The antigenic repertoire of premalignant and high-risk lesions

834 Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

Designing vaccines to prevent breast cancer recurrence or invasive disease

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

Immunotherapy for breast cancer: is it feasible?

Rybp interacts with Hippi and enhances Hippi-mediated apoptosis

Abstract PR007: Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC

Suchergebnisse filtern